
Latest News
We help inventions grow!
Dec 23, 2022
We are looking for new Antonin Holy and new drugs and diagnostics that can have a global impact and success
"i&i Bio invests in technology transfer with a strong focus on healthcare. We look for unique technologies that come from Czech and foreign science. We always try to find something new and unique, something that could bring great benefit to patients and also to our investors," says Jaromír Zahrádka for Fintag.cz. The podcast is in the Czech language.

Sep 28, 2022
Smart bandages not only capture pathogens, but also destroy them in no time. All they need is ordinary light.
Hospital-acquired infections are a problem that current technologies are not able to deal with effectively. However, this could change in the future; the Czech spin-off LAM-X a.s. is working on the development of a nanomaterial that not only passively prevents pathogens from entering open wounds, but can also actively destroy them ...

Sep 13, 2022
CasInvent Pharma raises €1.3M from KHAN-I and i&i Bio for the development of CK1 inhibitors for the treatment of cancers
CasInvent Pharma, an early-stage drug discovery company developing small-molecule compounds with anticancer properties, has raised an investment round of €1.3 million provided by KHAN-I and i&i Bio. With this funding, CasInvent will be strengthening its portfolio of CK inhibitors and progressing its lead compound to ...

Aug 22, 2022
Jaromír Zahrádka: Investments help science to serve people
According to Jaromír Zahrádka, director of the i&i Biotech investment fund, investing in science is like the proverbial chicken and egg. If there is a lack of investment, no new projects are created. And without interesting projects, it is impossible to get investors interested. So how to solve this dilemma?

i&i Prague Highlights
Highlights from i&i Bio
We have moved the investment part of our business to our associated venture capital firm, i&i Biotech Fund I. Here you can find the most important news from (i&i Bio).
The Advisory Committee of i&i Biotech Fund strengthened by renowned economist Daniel Münich
Jan 4, 2023
i&i Biotech Fund announces the launch of cooperation with Associate Professor Daniel Münich, who has joined the Fund's Advisory Committee. The renowned Czech economist will join the European Investment Fund's (EIF) delegate as a representative of the bio-innovation center, i&i Prague, ...
i&i Bio invests more than €1 M in Enzyre to help to advance pioneering diagnostic technology platform for hemophilia patients
Nov 30, 2022
Leading Czech businessmen have joined the support of the most promising scientific projects. Eight prominent entrepreneurs have contributed nearly €2 million to the i&i Biotech Fund (i&i Bio), an investment fund that specializes in finding and developing unique academic startups ...
i&i Bio invests more than €1 M in Enzyre to help to advance pioneering diagnostic technology platform for hemophilia patients
Nov 2, 2022
Enzyre, a company developing a breakthrough ambulant diagnostic technology for blood coagulation testing, today announced that it has successfully raised EUR 12 million Series A funding led by new investor Oost NL, with participation from i&i Biotech Fund, Demcon Investment ...
Nanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fund I
Sep 27, 2022
Nanoligent SL, a Spanish biotech company specialized in the development of cancer treatments based on unique protein conjugates, today announces the completion of a Seed financing round of total € 2.8 M. The final closing of the Seed round consists of € 1 M investment by i&i Biotech Fund I ...